Latest Skincare News

Page 2 of 2
Skin Elements Limited has locked in $2.5 million through a two-tranche placement to accelerate the commercial rollout of its SE Formula biotechnology products, offering investors discounted shares and options.
Ada Torres
Ada Torres
15 Oct 2025
Skin Elements Limited reported a 13% revenue increase and a 20% reduction in net loss for FY2025, as it progresses commercial roll-out of its natural biotech products including ECO-Nurture and SuprCuvr.
Ada Torres
Ada Torres
29 Aug 2025
McPherson’s Limited anticipates FY25 revenue around $139 million with a strong second-half EBITDA rebound, while its strategic shift to third-party wholesalers sets the stage for significant EBIT gains in FY26.
Victor Sage
Victor Sage
18 July 2025
Anagenics Limited’s licensed brand Bouf Haircare is outperforming expectations with strong early sales and promising royalty returns, signaling robust growth potential for the company’s intellectual property portfolio.
Victor Sage
Victor Sage
27 June 2025
Anagenics Limited’s proprietary hair regrowth technology powers the newly launched Bouf Haircare brand, which has achieved over $500,000 in sales in its first week, setting the stage for a lucrative royalty stream.
Victor Sage
Victor Sage
4 June 2025
Nuchev Limited has entered an exclusive sales agency agreement with Brauer Natural Medicines and H&S Brand Corporation, expanding its footprint in Australia's natural and complementary medicines sector. The deal covers key brands including Brauer, Skin Physics, and Rapid Loss, with potential for broader ANZ distribution.
Ada Torres
Ada Torres
1 May 2025
Adore Beauty Group Limited reported a modest 2.3% revenue increase to $103 million for H1 FY25, while profits declined 36.6% due to acquisition and restructuring expenses. The company is expanding its retail footprint with new store openings planned in 2025.
Logan Eniac
Logan Eniac
17 Feb 2025
Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.
Ada Torres
Ada Torres
31 Jan 2025
Bod Science Limited reports a modest net cash inflow of $51,000 for Q2 FY2025, supported by increased customer receipts and intellectual property sales, while navigating a complex Deed of Company Arrangement and pending acquisition.
Victor Sage
Victor Sage
24 Jan 2025

Browse the archive

Full archive